Myriad Genetics Inc
F:MYD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Myriad Genetics Inc
F:MYD
|
US |
|
C
|
Curtiss-Wright Corp
F:CWT
|
US |
|
Grenevia SA
F:8MF
|
PL |
|
Lagardere SA
F:LAG
|
FR |
|
A
|
Adaro Energy Indonesia TBK PT
F:A64
|
ID |
|
D
|
Diebold Nixdorf Inc
F:DBD
|
US |
|
T
|
Teladoc Health Inc
LSE:0LDR
|
US |
|
Luk Fook Holdings (International) Ltd
F:LUY1
|
HK |
|
M
|
Muenchener Rueckversicherungs Gesellschaft in Muenchen AG
DUS:MUV2
|
DE |
|
C
|
Carnival PLC
NYSE:CUK
|
UK |
|
I
|
Inversiones Aguas Metropolitanas SA
SGO:IAM
|
CL |
|
T
|
Tapestry Inc
XMUN:COY
|
US |
|
C
|
CVS Health Corp
DUS:CVS
|
US |
|
G
|
Green Dot Corp
XBER:5GN
|
US |
|
E
|
Energy Recovery Inc
F:5E2
|
US |
|
S
|
Sumitomo Realty & Development Co Ltd
SWB:RL2
|
JP |
|
M
|
Medifast Inc
SWB:MDF
|
US |
|
Staffline Group PLC
LSE:STAF
|
UK |
|
Staffline Group PLC
F:OSU
|
UK |
|
Telefonaktiebolaget LM Ericsson
F:ERCA
|
SE |
Bankruptcy Probability
Myriad Genetics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Myriad Genetics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Myriad Genetics Inc
NASDAQ:MYGN
|
584.3m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
449.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
200.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
169.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
123.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
71.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
46.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Myriad Genetics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Myriad Genetics Inc has total debt of 120.3m USD. This includes both short-term (0 USD) and long-term (120.3m USD) debt.
You can find a full breakdown on its Balance Sheet.
